200 related articles for article (PubMed ID: 29551085)
1. Ovarian Clear Cell Adenofibroma of Low Malignant Potential Developing Into Clear Cell Adenocarcinoma.
Yin Z; Peters S; Chokshi R; Heller D
Int J Surg Pathol; 2018 Sep; 26(6):578-580. PubMed ID: 29551085
[TBL] [Abstract][Full Text] [Related]
2. A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types.
Sugiyama T; Nishida T; Kataoka A; Okura N; Iwanaga S; Yakushiji M
Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):47-50. PubMed ID: 9076421
[TBL] [Abstract][Full Text] [Related]
3. Benign clear cell adenofibroma of the ovary. A case report with literature review.
Paşaoğlu O; Ciftçi E; Tel N; Ozalp S; Acikalin MF
Gynecol Obstet Invest; 2007; 64(1):36-9. PubMed ID: 17202822
[TBL] [Abstract][Full Text] [Related]
4. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
[TBL] [Abstract][Full Text] [Related]
5. Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes.
Kato H; Hatano Y; Makino H; Furui T; Morishige KI; Matsuo M
Abdom Radiol (NY); 2016 Dec; 41(12):2476-2483. PubMed ID: 27167231
[TBL] [Abstract][Full Text] [Related]
6. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
[TBL] [Abstract][Full Text] [Related]
7. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
Yamamoto S; Tsuda H; Takano M; Kita T; Kudoh K; Furuya K; Tamai S; Matsubara O
Mod Pathol; 2008 Feb; 21(2):115-24. PubMed ID: 18084257
[TBL] [Abstract][Full Text] [Related]
8. [Endometrioid adenofibroma of the ovary. An anatomo-clinical case report].
Chebrou DM; Provendier B; Chebrou C; Fetissof F; Ledoux A
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):254-6. PubMed ID: 8345148
[TBL] [Abstract][Full Text] [Related]
9. Benign and borderline clear cell adenofibromas of the ovary.
Bell DA; Scully RE
Cancer; 1985 Dec; 56(12):2922-31. PubMed ID: 4052962
[TBL] [Abstract][Full Text] [Related]
10. Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report.
Vasilakaki T; Skafida E; Arkoumani E; Grammatoglou X; Firfiris N; Manoloudaki K
Eur J Gynaecol Oncol; 2012; 33(2):230-2. PubMed ID: 22611972
[TBL] [Abstract][Full Text] [Related]
11. Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.
Bell DA; Scully RE
Am J Surg Pathol; 1985 Mar; 9(3):205-14. PubMed ID: 3993832
[TBL] [Abstract][Full Text] [Related]
12. Borderline clear cell adenofibroma with extensive hemorrhagic necrosis.
Liu JL; Chu PY; Yeh KT; Huang RH
Hematol Oncol Stem Cell Ther; 2010; 3(3):158-60. PubMed ID: 20890073
[TBL] [Abstract][Full Text] [Related]
13. Serous papillary cystic ovarian borderline tumor: case report.
Idotta R; Scopelliti P; Polimeni C; Lirosi MF
Clin Exp Obstet Gynecol; 2002; 29(4):293-6. PubMed ID: 12635749
[TBL] [Abstract][Full Text] [Related]
14. Mucinous adenofibroma of the ovary: case report of the endocrinologic findings.
Tohya T; Mizutani H; Katabuchi H; Miyazaki K; Okamura H
Gynecol Oncol; 1994 Aug; 54(2):218-21. PubMed ID: 8063250
[TBL] [Abstract][Full Text] [Related]
15. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma.
Roth LM; Langley FA; Fox H; Wheeler JE; Czernobilsky B
Cancer; 1984 Mar; 53(5):1156-63. PubMed ID: 6692303
[TBL] [Abstract][Full Text] [Related]
16. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
17. Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Mod Pathol; 2012 Jan; 25(1):122-30. PubMed ID: 21983935
[TBL] [Abstract][Full Text] [Related]
18. Ovarian endometrioid adenocarcinoma coexistent with benign and borderline endometrioid adenofibroma: a case report.
Ushijima K; Nishida T; Muraoka Y; Sugiyama T; Okura N; Shinagawa A; Imaishi K; Yakushiji M
J Obstet Gynaecol Res; 1998 Apr; 24(2):161-6. PubMed ID: 9631607
[TBL] [Abstract][Full Text] [Related]
19. Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI.
Takeuchi M; Matsuzaki K; Uehara H; Furumoto H; Harada M
Magn Reson Med Sci; 2013 Dec; 12(4):305-8. PubMed ID: 24172789
[TBL] [Abstract][Full Text] [Related]
20. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary.
Norris HJ
Int J Gynecol Pathol; 1993 Apr; 12(2):134-40. PubMed ID: 8463037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
